Financhill
Back

BMO All-Equity ETF Vs. Zenas BioPharma, Inc. Industry Stock Comparison

Buy
69

ZEQT.TO
BMO All-Equity ETF

Last Price:
$20.56
Seasonality Move:
1.65%
Buy
60

ZBIO
Zenas BioPharma, Inc.

Last Price:
$41.96
Seasonality Move:
0.59%
Buy
69
BMO All-Equity ETF (ZEQT.TO) is a Buy

Is BMO All-Equity ETF a Buy, Sell or Hold?

  • The current BMO All-Equity ETF [ZEQT.TO] share price is $20.60. The Score for ZEQT.TO is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
  • ZEQT.TO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
60
Zenas BioPharma, Inc. (ZBIO) is a Buy

Is Zenas BioPharma, Inc. a Buy, Sell or Hold?

  • The current Zenas BioPharma, Inc. [ZBIO] share price is $42.33. The Score for ZBIO is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • ZBIO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

ZEQT.TO Stock Price Chart

What is BMO All-Equity ETF's stock price today?

  • The BMO All-Equity ETF share price today is $20.60
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZEQT.TO is experiencing buying pressure, which is a positive indicator for future bullish movement.

ZBIO Stock Price Chart

What is Zenas BioPharma, Inc.'s stock price today?

  • The Zenas BioPharma, Inc. share price today is $42.33
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZBIO is experiencing buying pressure, which is a positive indicator for future bullish movement.

ZEQT.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.04 Buy
Relative Strength Index (14 RSI): 57.2 Buy
Chaikin Money Flow: 67039 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (20.15 - 20.61) Buy
Bollinger Bands (100): (19.25 - 20.47) Buy

ZBIO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.47 Buy
Relative Strength Index (14 RSI): 61.08 Buy
Chaikin Money Flow: 587345 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (35.32 - 39.82) Buy
Bollinger Bands (100): (17.72 - 34.64) Buy

ZEQT.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.41 Buy
20-day SMA: 20.48 Buy
50-day SMA: 20.34 Buy
200-day SMA: 18.65 Buy
8-day EMA: 20.44 Buy
20-day EMA: 20.42 Buy
50-day EMA: 20.25 Buy
200-day EMA: 19.02 Buy

ZBIO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 37.46 Buy
20-day SMA: 37.97 Buy
50-day SMA: 33.51 Buy
200-day SMA: 18.21 Buy
8-day EMA: 24.11 Buy
20-day EMA: 12.41 Buy
50-day EMA: 5.54 Buy
200-day EMA: 1.47 Buy

BMO All-Equity ETF Earnings Growth & ZEQT.TO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Zenas BioPharma, Inc. Earnings Growth & ZBIO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.65 per share, and an increase next year of $0.59 per share.

BMO All-Equity ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Zenas BioPharma, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):